✦ LIBER ✦

MHC class II-restricted tumor antigens and CD4+ T cells play a role in hematological malignancies as well as solid tumors

✍ Scribed by Rong-Fu Wang

Book ID: 117786977
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 20 KB
Volume: 22
Category: Article
ISSN: 1471-4906
DOI: 10.1016/s1471-4906(01)01986-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MHC class II-restricted tumor antigens a

MHC class II-restricted tumor antigens and CD4+ T cells play a role in hematological malignancies as well as solid tumors

✍ Graham Pawelec; Ludmila Müller; Wolfgang Wagner 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 37 KB

MHC class II restricted tumor antigens a

MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

✍ Suzanne L. Topalian 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 693 KB

The role of MHC class II-restricted tumo

The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity

✍ Rong-Fu Wang 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 294 KB

Malignant glioma cells use MHC class II

Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-γ-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4+ T-cell activation

✍ Jeanne M. Soos; Jeffrey I. Krieger; Olaf Stüve; Chelsea L. King; Juan Carlos Pat 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 615 KB

## Abstract Malignant gliomas (MGs), lethal human central nervous system (CNS) neoplasms, contain tumor infiltrating lymphocytes (TIL). Although MHC class II molecules are frequently detected on MG cells, suggesting that they may be capable of antigen (Ag) presentation to CD4^+^ T cells, deficienci